14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 7 Oct 2024

Trading levels for CERS

Fibonacci Support & Resistance Levels

Level Price
R3 1.76 3.26%
R2 1.73 1.99%
R1 1.72 1.21%
Price 1.70
S1 1.68 -1.34%
S2 1.66 -2.12%
S3 1.64 -3.40%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.11 24.12%
R2 2.04 20.00%
R1 1.78 4.71%
Price 1.70
S1 1.69 -0.588%
S2 1.68 -1.18%
S3 0 -

CERS Predictions History

1 year ago
JS predicted that CERS for 2023-07-19 is going $2.81 (-3.77%)

1 year ago
PredictionBot.Kathy predicted that CERS for 2023-07-19 is going $2.71 (-7.18%)

1 year ago
PredictionBot.Warren predicted that CERS for 2023-07-19 is going $2.73 (-6.41%)

3 years ago
cbrennem.228522 predicted that CERS for 2021-04-20 is going

Rank:

3 years ago
JS predicted that CERS for 2021-03-12 is going $6.42 (0.47%)

3 years ago
SHAMOO predicted that CERS for 2021-03-12 is going

3 years ago
JS predicted that CERS for 2020-12-23 is going $8.25 (0.98%)

3 years ago
Jessie Qu predicted that CERS for 2020-12-23 is going

Rank:

4 years ago
JS predicted that CERS for 2020-08-25 is going $6.74 (6.73%)

4 years ago
2poJeff predicted that CERS for 2020-08-25 is going $7.06 (3.37%)

Click to get the best stock tips daily for free!
ABOUT CERUS CORPORATION
Cerus
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed t...
GOLDEN STAR
Ticker Change Signal Date
WM
$207.93
0.558% Oct 01
VET
$9.77
7.06% Sep 30
FSK
$19.73
1.57% Sep 30
XOM
$115.82
5.84% Sep 27
HES
$133.61
5.43% Sep 27

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE